Medis Medical Imaging Systems BV
Medis Medical Imaging Systems is a privately-held Dutch software company that develops vendor-independent post-processing solutions for quantitative cardiovascular image analysis across CT, MRI, X-Ray, Ultrasound, and Intravascular modalities, serving hospitals, academic medical centers, and medical device partners globally.
- Company typePrivate
- Founded1994
- HeadquartersLeiden, Netherlands
- Headcount101–250
- GTM typeB2B
- OfferingSoftware
What Medis Medical Imaging Systems BV does
Medis Medical Imaging Systems B.V. is a privately-held Dutch medical imaging software company headquartered in Leiden, Netherlands, founded around 1989-1994 and operating for over 30 years. The company develops vendor-independent post-processing software for the quantitative analysis of cardiovascular images across all major imaging modalities—CT, MRI, X-Ray, Ultrasound, and Intravascular (IVUS/OCT). Its product portfolio comprises six core solutions: Medis QFR® (AI deep-learning-powered non-invasive coronary physiology assessment), Medis Suite MR (cardiac MRI post-processing), Medis Suite CT (cardiovascular CT analysis), Medis Suite XA (coronary and ventricular X-ray angiography), Medis Suite Ultrasound (cardiac deformation analysis), and Medis Suite Intravascular (IVUS/OCT offline evaluation).
The company sells primarily through a direct enterprise field sales motion targeting hospitals, medical centers, academic institutions, and medical device industry partners globally, supported by a consultative demo/trial sales process and multi-language capabilities (English, Japanese). Revenue is generated via subscription-based software licensing to healthcare institutions; pricing is quote-based and not publicly disclosed. The customer base spans interventional cardiologists, general cardiologists, radiologists, and clinical researchers, with named installations at Radboudumc, University of California, Brigham Health, University of Twente, Hospital San Juan, and Hospital Universitari Germans Trias i Pujol. QFR® has achieved the strongest regulatory and clinical credibility among the products, receiving Class I recommendation in the 2024 ESC Guidelines for chronic coronary syndromes and non-inferiority confirmation in the PIONEER IV trial. The company operates with 101-250 employees, maintains an active Academy education platform, and shows no disclosed funding rounds beyond a minor Van Herk Ventures investment in 2018—indicating sustained independent operation without majority institutional control.
Medis Medical Imaging Systems BV firmographics
Firmographics- Name
- Medis Medical Imaging Systems BV
- Legal name
- Medis Medical Imaging Systems B.V.
- Website
- https://medis.nl
- Company type
- Private
- Founded year
- 1994
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Medis Medical Imaging Systems is a privately-held Dutch software company that develops vendor-independent post-processing solutions for quantitative cardiovascular image analysis across CT, MRI, X-Ray, Ultrasound, and Intravascular modalities, serving hospitals, academic medical centers, and medical device partners globally.
- Ownership category
- akta.pro rank
Medis Medical Imaging Systems BV industry classification
Industry- Product category
- Cardiovascular Imaging Software
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industry
- SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)
Keywords
Where Medis Medical Imaging Systems BV is headquartered
LocationHeadquarters
- HQ city
- Leiden
- HQ country
- Netherlands
- HQ region
- Europe
Offices1 record
Markets served
Medis Medical Imaging Systems BV business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Imaging Software Licenses: Software solutions sold to healthcare institutions including hospitals, research centers, and cardiology practices. Revenue generated through licensing of proprietary cardiac imaging software products (Medis QFR, Medis Suite MR/CT/XA/Ultrasound, Intravascular).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise licensing for hospitals and medical centers |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Medis Medical Imaging Systems BV product offering
Product offeringCore offering
Medis develops and licenses vendor-independent post-processing software for the quantitative analysis of cardiovascular images across CT, MRI, X-Ray, Ultrasound, and Intravascular (IVUS/OCT) modalities. Its portfolio includes the AI-powered Medis QFR® for non-invasive coronary physiology assessment and the Medis Suite family (MR, CT, XA, Ultrasound, Intravascular) for cardiac imaging post-processing. Products are sold as subscription-based licenses to hospitals, medical centers, and academic research institutions globally.
Product overview
Medis Medical Imaging Systems develops a comprehensive suite of vendor-independent cardiac imaging software solutions. The portfolio includes Medis QFR® (AI-powered non-invasive coronary physiology assessment), Medis Suite MR (cardiac MRI post-processing), Medis Suite CT (cardiovascular CT analysis), Medis Suite XA (coronary and ventricular X-ray analysis), Medis Suite Ultrasound (cardiac ultrasound deformation analysis), and Medis Suite Intravascular (IVUS and OCT analysis). All solutions are designed to support healthcare professionals across CT, MRI, X-Ray, and Ultrasound imaging modalities for quantitative cardiac analysis.
Differentiator
Problem solved
Functional benefit
Brands
- Medis QFR®: Fast, user-friendly, non-invasive coronary physiology powered by AI deep learning.
- Medis Suite MR
- Medis Suite CT
- Medis Suite XA
- Medis Suite Ultrasound
- Medis Suite Intravascular
Products and services
- Medis QFR® AI deep-learning-powered software for fast, user-friendly, non-invasive coronary physiology assessment via Quantitative Flow Ratio (QFR) computed from angiography. Used by interventional cardiologists for PCI guidance as a non-invasive alternative to wire-based FFR.
- Medis Suite MR Comprehensive, time-saving, validated post-processing software for cardiac MRI analysis, providing workflow automation and tools such as Inward Displacement for objective quantification of wall motion abnormalities. Used by radiologists and cardiologists for clinical reporting and research.
- Medis Suite CT Vendor-independent post-processing software for advanced quantitative analysis of cardiovascular CT cases, including left ventricular global longitudinal strain assessment for risk stratification (e.g., TAVI patients). Used by cardiac CT imaging teams.
- Medis Suite XA Industry-leading, vendor-independent software for quantitative coronary and ventricular X-ray angiography analysis, described as the de facto standard for quantitative angiography. Supports high-volume analyses with limited personnel for clinical trials and routine practice.
- Medis Suite Ultrasound Vendor-independent post-processing software for advanced deformation analysis on cardiac ultrasound imaging. Used by echocardiography labs and cardiology departments.
- Medis Suite Intravascular Vendor-independent post-processing software for offline evaluation of IVUS (Intravascular Ultrasound) and OCT (Optical Coherence Tomography) studies. Used by interventional cardiology teams for intravascular imaging review.
Quantifiable outcome
- PIONEER IV trial confirms QFR-guided PCI is non-inferior to usual-care PCI including FFR, iFR, IVUS, and OCT guidance
- +2 more outcomes
Companies that use Medis Medical Imaging Systems BV
Customer profileNamed customers6 records
Segments4 records
Ideal customer profiles2 records
Medis Medical Imaging Systems BV technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature6 records
Medis Medical Imaging Systems BV partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights5 records
Medis Medical Imaging Systems BV competitors and assessment
Company assessmentDirect peers
- HeartFlow: Direct competitor in non-invasive coronary physiology assessment; HeartFlow's CT-derived FFR directly rivals Medis QFR for the same clinical use case of replacing invasive wire-based FFR in cath lab and diagnostic workflows.
- Pie Medical Imaging: Direct Dutch-headquartered peer specializing in quantitative cardiovascular imaging analysis software (CT, MR, XA) used by interventional cardiologists and radiologists. Operates in the same vendor-independent post-processing niche as Medis with overlapping modality coverage.
- Circle Cardiovascular Imaging: Direct competitor in cardiac MR and CT post-processing software (cvi42), widely used in academic cardiovascular imaging centers; competes head-to-head with Medis Suite MR and Medis Suite CT.
Emerging players
- Aidoc: Broader imaging-AI platform with cardiac-adjacent triage and analytics; competes for hospital AI budgets and PACS integrations that could overlap with Medis' modality-specific post-processing.
- CathWorks: Emerging competitor offering non-hyperemic FFR (FFRangio) computed in the cath lab; competes with QFR in the same procedural coronary physiology decision-support category.
- Elucid Bioimaging: Emerging cardiovascular imaging AI company providing quantitative CT plaque analysis; overlaps with Medis Suite CT in delivering cardiovascular CT quantification for risk assessment.
- Artrya: Emerging AI imaging player focused on coronary CT analysis (Salus) for cardiovascular disease detection; overlaps with Medis' CT post-processing for risk stratification and coronary assessment.
Broad incumbents
- Philips (TomTec / IntelliSpace Portal): Broad incumbent that acquired TomTec (cardiac imaging post-processing) and bundles it with IntelliSpace Portal; competes via OEM-bundled cardiac analysis offerings across CT, MR and ultrasound.
- Siemens Healthineers (syngo.via): Broad incumbent offering syngo.via for cardiac CT/MR post-processing as part of its imaging hardware portfolio; leverages installed-base advantage to compete against Medis' vendor-independent suite.
- GE HealthCare (Edison / AW Workstation): Broad incumbent offering cardiac post-processing on its AW Workstation and Edison AI platform; competes with Medis primarily via OEM-bundled analytics sold alongside CT and MR scanners.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key highlights6 records
Customer concentration
Medis Medical Imaging Systems BV social profiles
Digital presenceMedis Medical Imaging Systems BV financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medis Medical Imaging Systems BV leadership team
Management profileNumber of profiles
Profiles3 records
Medis Medical Imaging Systems BV funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medis Medical Imaging Systems BV M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medis Medical Imaging Systems BV
What does Medis Medical Imaging Systems BV do?
Medis develops and licenses vendor-independent post-processing software for the quantitative analysis of cardiovascular images across CT, MRI, X-Ray, Ultrasound, and Intravascular (IVUS/OCT) modalities. Its portfolio includes the AI-powered Medis QFR® for non-invasive coronary physiology assessment and the Medis Suite family (MR, CT, XA, Ultrasound, Intravascular) for cardiac imaging post-processing. Products are sold as subscription-based licenses to hospitals, medical centers, and academic research institutions globally.
Is Medis Medical Imaging Systems BV a public or private company?
Medis Medical Imaging Systems BV is a private company. It is classified as venture growth investor backed and is currently operating.
When was Medis Medical Imaging Systems BV founded?
Medis Medical Imaging Systems BV was founded in 1994. It employs 101 to 250 people.
Where is Medis Medical Imaging Systems BV based?
Medis Medical Imaging Systems BV is headquartered in Leiden, Netherlands, in the Europe region.
How does Medis Medical Imaging Systems BV make money?
One revenue line is on record: medical Imaging Software Licenses.
Who are Medis Medical Imaging Systems BV's main competitors?
Direct peers on record are HeartFlow, Pie Medical Imaging and Circle Cardiovascular Imaging. Emerging players are Aidoc, CathWorks, Elucid Bioimaging and Artrya. Broad incumbents are Philips (TomTec / IntelliSpace Portal), Siemens Healthineers (syngo.via) and GE HealthCare (Edison / AW Workstation).
Does Medis Medical Imaging Systems BV have an API?
No public API is recorded for Medis Medical Imaging Systems BV.
What industry is Medis Medical Imaging Systems BV in?
Medis Medical Imaging Systems BV's product category is Cardiovascular Imaging Software. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML). Its NAICS code is 513210 and its SIC code is 7372.